These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1126966)

  • 41. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP; Remme J
    East Afr Med J; 1985 Jan; 62(1):12-20. PubMed ID: 4006810
    [No Abstract]   [Full Text] [Related]  

  • 43. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An assessment of the effectiveness of the measles immunization programme in Lagos, Nigeria.
    Ogunmekan DA; Bracken P; Marshall WC
    Ann Trop Med Parasitol; 1981 Feb; 75(1):87-92. PubMed ID: 7271359
    [No Abstract]   [Full Text] [Related]  

  • 45. The plaque-neutralization test as a measure of prior exposure to measles virus.
    Orenstein WA; Albrecht P; Herrmann KL; Bernier R; Bart KJ; Rovira EZ
    J Infect Dis; 1987 Jan; 155(1):146-9. PubMed ID: 3794399
    [No Abstract]   [Full Text] [Related]  

  • 46. Negative seroconversion and circulating interferon in children vaccinated with live measles vaccine.
    Izbický A; Drevo M; Domorázková E; Slonin D
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):191-4. PubMed ID: 562373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 48. [The duration and intensity of measles immunity after a repeat inoculation against this infection].
    Bolotovskiĭ VM; Mikheeva IV; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):45-9. PubMed ID: 2385988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 50. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 51. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
    de Haas PW; Masurel N; Anker WJ
    Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antibody response to different measles virus antigens under various conditions of immunization.
    Norrby E; Salmi AA; Vandvik B; Hammarskjöld B; Panelius M
    Adv Exp Med Biol; 1972; 31(0):49-69. PubMed ID: 4212389
    [No Abstract]   [Full Text] [Related]  

  • 53. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 55. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 56. [Humoral immunity indices of measles in reinoculated schoolchildren].
    Miroshnikova NK; Smorodinova IP; Smorodintsev AA; Petrova VN
    Tr Inst Im Pastera; 1983; 61():145-51. PubMed ID: 6235627
    [No Abstract]   [Full Text] [Related]  

  • 57. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles antibody in previously immunized children. The need for revaccination.
    Linnemann CC; Dine MS; Bloom JE; Schiff GM
    Am J Dis Child; 1972 Jul; 124(1):53-7. PubMed ID: 5033750
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Measles immunity and revaccination.
    Balfour HH; Quie PG; Kalis JM
    JAMA; 1976 May; 235(19):2079. PubMed ID: 946524
    [No Abstract]   [Full Text] [Related]  

  • 60. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.